CHCZX
Price
$13.06
Change
-$0.01 (-0.08%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

CHCZX vs RPTIX

Header iconCHCZX vs RPTIX Comparison
Open Charts CHCZX vs RPTIXBanner chart's image
AB Discovery Growth Z
Price$13.06
Change-$0.01 (-0.08%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CHCZX vs RPTIX Comparison Chart
Loading...
VS
CHCZX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHCZX is a StrongBuy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. CHCZX (2.81B). RPTIX pays higher dividends than CHCZX: RPTIX (0.18) vs CHCZX (0.00). CHCZX was incepted earlier than RPTIX: CHCZX (10 years) vs RPTIX (9 years). CHCZX is a more actively managed with annual turnover of: 70.00 vs. RPTIX (21.70). RPTIX has a lower initial minimum investment than CHCZX: RPTIX (500000) vs CHCZX (2000000). CHCZX annual gain was more profitable for investors over the last year : 31.52 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. CHCZX (13.07).
CHCZXRPTIXCHCZX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years9 years-
Gain YTD16.3999.127180%
Front LoadN/AN/A-
Min. Initial Investment2000000500000400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.81B31.4B9%
Annual Yield % from dividends0.000.18-
Returns for 1 year31.5214.81213%
Returns for 3 years-22.86-13.57168%
Returns for 5 years13.0715.0987%
Returns for 10 years34.69N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp